[Trial of device that is not approved or cleared by the U.S. FDA]

This trial has been identified as being associated with a clinical device that has not been approved or cleared by the US Food and Drug Administration. Under the terms of US Public Law 110-85, Title VIII, Section 801, the details of this study are not available to the public.

First Received: August 10, 2009 No Changes Posted

Sponsor:	AspenBio Pharma, Inc.
Information provided by:	AspenBio Pharma, Inc.
ClinicalTrials.gov Identifier:	NCT00956618

Responsible Party:	AspenBio Pharma, Inc. ( Robert Caspari/Chief Operating Officer, Chief Medical Officer )
Study ID Numbers:	AB10-001
Study First Received:	August 10, 2009
Last Updated:	August 10, 2009
ClinicalTrials.gov Identifier:	NCT00956618 History of Changes
Health Authority:	United States: Institutional Review Board

ClinicalTrials.gov processed this record on February 04, 2010